Literature DB >> 2912060

The problem of diabetic renal failure in the United States: an overview.

S Teutsch1, J Newman, P Eggers.   

Abstract

Native Americans, blacks, and other minorities are at high risk for diabetic renal failure, most of which is caused by non-insulin-dependent diabetes. Many of these patients receive care in publicly supported health programs. Recent evidence of the efficacy of hypertension control in slowing the decline in renal function and our ability to detect those at highest risk for renal deterioration with inexpensive microalbuminuria tests suggest major opportunities for concerted efforts to reduce the incidence of end-stage renal disease. Guidelines for management of high-risk patients are needed to translate effective management strategies into routine clinical practice.

Entities:  

Mesh:

Year:  1989        PMID: 2912060     DOI: 10.1016/s0272-6386(89)80106-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Should we be screening for early diabetic renal disease?

Authors:  J Stephenson
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

2.  TEM stereometric analyses of glomeruli in aging OVE26 transgenic diabetic mice.

Authors:  Jennifer M Teiken; Paul N Epstein; Edward C Carlson
Journal:  Am J Nephrol       Date:  2011-06-10       Impact factor: 3.754

3.  Renal replacement treatment for diabetic patients in Newcastle upon Tyne and the Northern region, 1964-88.

Authors:  C Catalano; T H Goodship; J S Tapson; M K Venning; R M Taylor; G Proud; W M Tunbridge; R W Elliot; M K Ward; K G Alberti
Journal:  BMJ       Date:  1990-09-15

Review 4.  End-stage renal disease and race: an overview and perspective.

Authors:  R Ferguson
Journal:  J Natl Med Assoc       Date:  1991-09       Impact factor: 1.798

5.  Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.

Authors:  R F Dyck; L Tan
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.